Although PON2 upregulation has been described in several tumors, the significance of enzyme overexpression and the effect induced by such dysregulation on cancer cell phenotypes (cell viability, migration and invasive capacity, metabolic rate, resistance to radio- and chemotherapy, etc.), remain only partly understood. The gene discussed is PON2; the disease is cancer.